Fly News Breaks for March 10, 2015
IART
Mar 10, 2015 | 10:58 EDT
Piper Jaffray believes Integra LifeSciences will be a faster growing, more profitable company once the spinoff of its spine business is completed in the second half of 2015. The firm assumed coverage of the stock with an Overweight rating and $67 price target.
News For IART From the Last 2 Days
There are no results for your query IART